CompletedNot Applicable

Fluoroscopy Versus Ultrasound Guidance for Sacral Lateral Branch Radiofrequency Ablation

Turkey (Türkiye)60 participantsStarted 2022-09-01

Plain-language summary

Sacroiliac joint is a diarthroidal and synovial joint that receives sensory innervatin by the sacral lateral branches ( commonly S1-3, with variable contributions from L5 dorsal ramus and S4 lateral branch). Sacral lateral branch radiofrequency ablation and block techniques are widely used for the management of sacroiliac joint pain. With the increasing use of ultrasound technology in pain medicine, the ultrasound guided approaches gained popularity. To our knowledge, there are no randomized controlled trials comparing the ultrasound and fluoroscopy approaches for sacral lateral branch radiofrequency ablation. This study aims to compare the ultrasound and fluoroscopy guidance techniques for sacral lateral branch radiofrequency ablation.

Who can participate

Age range

18 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Low back pain due to sacroiliac joint dysfunction \>6 months with a score ≥ 4 on a numeric rating scale. * 50% pain relief after prognostic sacral lateral branch block * At least 3 positive physical examination maneuvers \[ Faber ( flexioni abduction and external rotation), POSH (posteripr shear), REAB ( resisted abduction), Gaenslen's test, Distraction test\] * Refractory to conservative therapy Exclusion Criteria: The exclusion criteria were; * Uncontrolled psychiatric or neurological illness * Sacroiliac joint pain due to other disorders, * Lumbar radiculopathy * Rheumatological diseases * Systemic active infections * Malignancies, previous surgery on the affected sacroiliac joint, * History of traumatic hip injury, * History of bleeding disorders, * Platelet values \< 150.000 / µl, * Sacroiliac joint injection within the preceding 3 months, * Allergy to local anesthetics and steroids, * Pregnancy, inability to concent, Implanted pacemaker or defibrilator.

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Change in pain numerical rating score from baseline

Timeframe: 3 months

Trial details

NCT IDNCT05520463

SponsorDiskapi Teaching and Research Hospital

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2023-06-25

View on ClinicalTrials.gov More Sacroiliac Joint Arthritis trials